Covid-19: See latest data on suppliers and inventory

SANOFI PASTEUR logo

SANOFI PASTEUR

PSF Verified
2, Avenue Pont Pasteur cedex 07, Lyon 69367, France
Sanofi Pasteur is the vaccine division of Sanofi. Sanofi Pasteur SA develops, manufactures, and supplies vaccines in France and internationally. The company provides vaccines for bacterial and viral diseases, including pertussis, diphtheria, typhoid fever, poliomyelitis, influenza, and mumps. It has production sites in France, the United States, Canada, China, Thailand, and Argentina. The company was formerly known as Aventis Pasteur S.A. and changed its name to Sanofi Pasteur SA in 2004.
DUNS #:
086723285
CAGE Code:
7V915
Type:
Manufacturer
Employees:
10,000-50,000
Annual Revenue:
$1B-$10B
Year Founded:
2004
Country of Origin:
France
Sectors Served:
US Federal, US State, US Local, Private Sector, Non-US Public Sector
Company Security Level:
Unknown
Credit Card Usage:
Unknown

Specialties and Expertise:

Biotechnology, Health Care, Pharmaceutical, Influenza Vaccines, Pediatric Vaccines, Polio Injectable Vaccines, Severe Acute Respiratory Syndrome (SARS) Vaccine, Coronavirus Vaccine Candidate, Yello...

COVID-19 Supplies1

Are you making PPE or ventilators for COVID-19?
Let us know
Categories
Products Available
Inventory/Capacity
Certification
Available Contracts
Contact Info
Vaccines and Therapeutics
Kevzara
no data
no data
no data
no data

Contact Info3

Size and minority status

Size
Other than small business
Ownership
African American
Alaska Native
Asian-Indian
Asian-Pacific
Hispanic
Minority-Unspecified
Native American
Native Hawaiian
Tribal
Unspecified
Veteran
Woman
Government Set-Aside Programs
AbilityOne
HUBZone
SBA 8(a)
SDVOSB
Small Disadvantaged Business (SDB)
Woman Owned Small Business (WOSB)

Commodity Codes14

PRODUCTS AND SERVICES3

Sanofi Pasteur Vaccines
2 past experiences
Sanofi Pasteur develops, manufactures, and supplies vaccines for bacterial and viral diseases, including pertussis, diphtheria, typhoid fever, poliomyelitis, influenza, and mumps.
Flublok Quadrivalent Influenza Vaccine
Flublok Quadrivalent is a vaccine for the prevention of influenza disease caused by influenza A and B given to people 18 years of age and older.
Kevzara
Kevzara is a fully-human monoclonal antibody for rheumatoid arthritis that inhibits the interleukin-6 (IL-6) pathway by binding and blocking the IL-6 receptor. The med is on clinical trails to combat Covid-19 coronavirus infection.

Past experience2

other
Influenza Vaccine and COVID-19 program
Sanofi has entered into an agreement with BARDA to establish facilities in the US for the production of an adjuvanted recombinant va...
other
Kevzara Vaccine against COVID-19
Sanofi and Regeneron Pharmaceuticals have started a clinical trial program evaluating Kevzara a rheumatoid arthritis drug to treat h...

Existing Contracts2

Contract Vehicle Type
Contract Name
Contract #
Who Can Use
Managing Organization
Exp. Date
Cooperative Contracts
State of California Leveraged Procurement Agreements (LPAs)
1-10-65-40E
State & Local (In most cases). Refer to the Resources Link.
Sate of California Department of General Services (DGS)
Dec 31, 2019
no data
no data
V797D-50457
Federal
US General Services Administration (GSA)
Dec 14, 2020

Locations served2

  • United States 1 location
  • France all
My Notes
Contact
My Notes